| |
| | Emerging Pharma - News & Events |
 | | Sulodexide is a glycosaminoglycan, a new class of drug that has demonstrated nephroprotective activity, and is promising in the treatment of diabetic nephropathy. |
 | | He added that the delayed onset of effect, in conjunction with experimental data in animals, suggested sulodexide probably interferes with the glomerular structure of the diabetic kidney, and possibly the remodeling of diabetic nephropathy. |
 | | "As you know the major cause of mortality in patients with diabetic nephropathy is stroke and MI; perhaps now we have a unique chance to treat, with only one drug, both the cardiovascular and renal complications of diabetic angiopathy," he said. |
| www.emergingp.com /main/news00.asp (536 words) |
|